Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Nevro
Nevro
Abbott wins FDA spinal cord stimulation approval to challenge Nevro for back pain market
Abbott wins FDA spinal cord stimulation approval to challenge Nevro for back pain market
Medtech Dive
Abbott Labs
Medtech
FDA
Spinal Cord Stimulation
back pain
BurstDR
Nevro
Flag link:
Nevro’s AI-Based Spinal Cord Stimulation Device for Chronic Pain Receives FDA Approval
Nevro’s AI-Based Spinal Cord Stimulation Device for Chronic Pain Receives FDA Approval
Xtalks
Medtech
devices
Nevro
FDA
Senza HFX
chronic pain
Spinal Cord Stimulation
Flag link:
Boston Scientific pays $85M to settle long-running patent dispute with Nevro
Boston Scientific pays $85M to settle long-running patent dispute with Nevro
Medtech Dive
devices
Medtech
patents
intellectual property
Boston Scientfic
Nevro
Flag link:
25 Most Attractive Medtech M&A Targets in 2022
25 Most Attractive Medtech M&A Targets in 2022
Medical Devices and Diagnostics Industry
Medtech
devices
M&A
AtriCure
Axonics
Cardiovascular Systems
Conmed
Glaukos
Inari Medical
InMode
Inspire Medical Systems
iRhythm Technologies
NeuroPace
Nevro
NuVasive
OrthoPediatrics
Paragon 28
Penumbra
Pulmonx
Shockwave Medical
SI-BONE
Silk Road Medical
Staar Surgical
Tandem Diabetes
Treace Medical Concepts
TELA Bio
ViewRay
Flag link:
Nevro Takes Medtronic to Task Over Diabetic Neuropathy Data
Nevro Takes Medtronic to Task Over Diabetic Neuropathy Data
Medical Devices and Diagnostics Industry
devices
Nevro
Medtronic
FDA
Spinal Cord Stimulation
diabetic neuropathy
Flag link:
Boston Sci Scores Critical Win in Patent Dispute with Nevro
Boston Sci Scores Critical Win in Patent Dispute with Nevro
Medical Devices and Diagnostics Industry
devices
Boston Scientific
patents
Nevro
Spinal Cord Stimulation
Flag link:
Nevro touts data supporting use of Senza system to treat diabetic neuropathy pain
Nevro touts data supporting use of Senza system to treat diabetic neuropathy pain
Mass Device
devices
Nevro
Senza
diabetic neuropathy
chronic pain
Flag link:
FDA flags 428 spinal cord stimulator patient deaths, urges more tests before implant
FDA flags 428 spinal cord stimulator patient deaths, urges more tests before implant
Medtech Dive
FDA
spinal cord stimulator
patient deaths
devices
Abbott Labs
Medtronic
Nevro
Boston Scientific
Flag link:
2019 was all about execution for smaller device makers
2019 was all about execution for smaller device makers
EP Vantage
devices
Abiomed
Cantel Medical
Cardiovascular Systems
Conmed
El.En.
Getinge
Guardant Health
ICU Medical
Inogen
Inspire Medical
LeMaitre Vascular
LivaNova
Meridian Bioscience
Merit Medical
Natera
Nevro
Qiagen
Sectra
TaiDoc Technology
Flag link:
Abbott alleges ex-marketing exec lifted its neuromod marketing playbook
Abbott alleges ex-marketing exec lifted its neuromod marketing playbook
Mass Device
Abbott Labs
devices
neuromodulation
Nevro
Flag link:
Judge sanctions Boston Scientific lawyers in Nevro patent row
Judge sanctions Boston Scientific lawyers in Nevro patent row
Mass Device
Boston Scientific
Nevro
devices
patents
neurostimulation
Flag link:
The Winners And Losers Of JP Morgan Monday
The Winners And Losers Of JP Morgan Monday
Forbes
JPMHC 2018
Cellular Biomedicine
Alder Biopharmaceuticals
Nevro
Insulet
PTC Therapeutics
Axovant Sciences
Momenta
Natus Medical
Oxford Immunotec
EXACT Sciences
Flag link:
Back to court: Nevro files new patent infringement suit against Boston Scientific
Back to court: Nevro files new patent infringement suit against Boston Scientific
Mass Device
Nevro
Boston Scientific
devices
patents
HF10
Senza
Spinal Cord Stimulation
Flag link:
FDA approves new leads for Nevro’s Senza spinal cord stimulator
FDA approves new leads for Nevro’s Senza spinal cord stimulator
Mass Device
FDA
Nevro
Senza
spinal cord stimulator
devices
Flag link:
FDA approves Nevro's Senza pain device ahead of schedule
FDA approves Nevro's Senza pain device ahead of schedule
Mass Device
FDA
Nevro
devices
Senza
spinal cord stimulator
Flag link:
Nevro lands $58M for pain device
Nevro lands $58M for pain device
Nevro
funding
Flag link:
Medtronic COO DeMane named Nevro CEO
Medtronic COO DeMane named Nevro CEO
Medtronic
Nevro
Spinal Cord Stimulation
Flag link: